Cell-bound complement activation products associate with lupus severity in SLE.
Arriens C, Alexander RV, Narain S, Saxena A, Collins CE, Wallace DJ, Massarotti E, Conklin J, Kalunian KC, Putterman C, Ramsey-Goldman R, Buyon JP, Askanase A, Furie RA, James JA, Bello GA, Manzi S, Ahearn J, O'Malley T, Weinstein A, Dervieux T.
Arriens C, et al.
Lupus Sci Med. 2020 Apr;7(1):e000377. doi: 10.1136/lupus-2019-000377.
Lupus Sci Med. 2020.
PMID: 32371480
Free PMC article.